Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
PRESTIGE BIOPHARMA LIMITED
🇸🇬
Singapore
Country
🇸🇬
Singapore
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
einpresswire.com
·
2 months ago
Key Trastuzumab Biosimilars Market Trend 2024-2033: Focus on New Product Launches
Trastuzumab biosimilars market to grow from $4.27B in 2023 to $5.43B in 2024, reaching $14.69B by 2028, driven by market expansion, patent expirations, and competitive pricing.
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy